BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29858106)

  • 1. Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: The Freiburg preeclampsia H.E.L.P.-Apheresis study.
    Winkler K; Contini C; König B; Krumrey B; Pütz G; Zschiedrich S; Pecks U; Stavropoulou D; Prömpeler H; Kunze M; Markfeld-Erol F
    Pregnancy Hypertens; 2018 Apr; 12():136-143. PubMed ID: 29858106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.
    Thadhani R; Hagmann H; Schaarschmidt W; Roth B; Cingoez T; Karumanchi SA; Wenger J; Lucchesi KJ; Tamez H; Lindner T; Fridman A; Thome U; Kribs A; Danner M; Hamacher S; Mallmann P; Stepan H; Benzing T
    J Am Soc Nephrol; 2016 Mar; 27(3):903-13. PubMed ID: 26405111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia.
    Thadhani R; Kisner T; Hagmann H; Bossung V; Noack S; Schaarschmidt W; Jank A; Kribs A; Cornely OA; Kreyssig C; Hemphill L; Rigby AC; Khedkar S; Lindner TH; Mallmann P; Stepan H; Karumanchi SA; Benzing T
    Circulation; 2011 Aug; 124(8):940-50. PubMed ID: 21810665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.
    Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D
    Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.
    Stolz M; Zeisler H; Heinzl F; Binder J; Farr A
    Pregnancy Hypertens; 2018 Jan; 11():54-60. PubMed ID: 29523274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
    Cui L; Shu C; Liu Z; Tong W; Cui M; Wei C; Tang JJ; Liu X; Hu J; Jiang J; He J; Zhang DY; Ye F; Li Y
    Pregnancy Hypertens; 2018 Jul; 13():127-132. PubMed ID: 30177039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia.
    Winkler K; Lorey C; Contini C; Augustinski V; Pütz G; Röthele E; Benner A; Fuchs H; Pecks U; Markfeld-Erol F; Kunze M
    Pregnancy Hypertens; 2024 Jun; 36():101128. PubMed ID: 38728925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: Report of two cases from a discontinued phase II trial.
    Haddad B; Lefèvre G; Rousseau A; Robert T; Saheb S; Rafat C; Bornes M; Petit-Hoang C; Richard F; Lecarpentier E; Tsatsaris V; Guibourdenche J; Corchia A; Rondeau E; Simon T; Hertig A
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():70-74. PubMed ID: 30326377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
    Tang P; Xu J; Xie BJ; Wang QM
    Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
    Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients.
    Zhu X; Chen L; Li R
    Clin Exp Hypertens; 2020 Oct; 42(7):601-607. PubMed ID: 32338084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
    Ohkuchi A; Hirashima C; Matsubara S; Takahashi K; Matsuda Y; Suzuki M
    Hypertension; 2011 Nov; 58(5):859-66. PubMed ID: 21947468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort.
    Saleh L; Verdonk K; Jan Danser AH; Steegers EA; Russcher H; van den Meiracker AH; Visser W
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():121-6. PubMed ID: 26927894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
    Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):93-99. PubMed ID: 27256927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.